JHCB — JOHN HANCOCK EXCHANGE TRADED
As of Q2 2026, 5 SEC-registered investment managers reported holding JHCB (JOHN HANCOCK EXCHANGE TRADED) in their latest 13F filings, with a combined reported value of $9.12M across 430.03K shares. That is -17.6% by share count (-92.06K shares) versus the previous quarter, while reported value moved -17.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 3 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 194.98K | $4.14M | 0.00% | Reduce |
| Goldman Sachs Group history | 145.93K | $3.10M | 0.00% | Reduce |
| Citadel Advisors history | 72.39K | $1.54M | 0.00% | Reduce |
| JPMorgan Chase & Co history | 16.72K | $356.70K | 0.00% | New |
| Morgan Stanley history | 1 | $40 | 0.00% | Hold |
Q1 2026 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 288.27K | $6.10M | 0.01% | Hold |
| Goldman Sachs Group history | 149.42K | $3.16M | 0.00% | New |
| Citadel Advisors history | 84.40K | $1.79M | 0.00% | New |
| Morgan Stanley history | 1 | $35 | 0.00% | Reduce |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 288.27K | $6.20M | 0.01% | Reduce |
| Morgan Stanley history | 2 | $47 | 0.00% | Hold |
Q3 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 717.21K | $15.58M | 0.01% | Add |
| JPMorgan Chase & Co history | 33.77K | $733.46K | 0.00% | New |
| Citadel Advisors history | 25.25K | $548.32K | 0.00% | New |
| Morgan Stanley history | 2 | $54 | 0.00% | Hold |
Q2 2025 — 4 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 513.04K | $11.00M | 0.01% | Reduce |
| UBS Group AG history | 80 | $1.71K | 0.00% | Reduce |
| Morgan Stanley history | 2 | $55 | 0.00% | Hold |
| Morgan Stanley history | 2 | $55 | 0.00% | Hold |
Q1 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Manulife Financial history | 643.04K | $13.65M | 0.01% | Reduce |
| Citadel Advisors history | 34.73K | $737.42K | 0.00% | Reduce |
| Citadel Advisors history | 34.73K | $737.42K | 0.00% | Reduce |
| UBS Group AG history | 267 | $5.67K | 0.00% | New |
| Morgan Stanley history | 2 | $50 | 0.00% | Add |
| Morgan Stanley history | 2 | $50 | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 16.72K sh · $356.70K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 7 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Manulife Financial | 194.98K | 288.27K | 288.27K | 717.21K | 513.04K | 643.04K | 996.38K | 1.20M | 1.40M | 1.50M | 1.64M | 1.40M | 1.40M | 1.40M | 1.45M | 1.45M | 1.45M | 1.50M | 1.54M | 1.56M |
| Goldman Sachs Group | 145.93K | 149.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 72.39K | 84.40K | — | 25.25K | — | 34.73K | 65.64K | 21.22K | 13.89K | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 16.72K | — | — | 33.77K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | — | 1 | 1 | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | 1 | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | — | — | — | — | 80 | 267 | — | 7.10K | — | — | 211 | — | 1.09K | 274 | — | 647 | 215 | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details